WHO ICTRP trial
Randomized Controlled Trial for H.pylori third line eradication therapy: PPI vs…
JPRN-UMIN000016336 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000016336 |
|---|---|
| Public title | Randomized Controlled Trial for H.pylori third line eradication therapy: PPI vs PCAB |
| Scientific title | Randomized Controlled Trial for H.pylori third line eradication therapy: PPI vs PCAB - PCAB-based H.pylori third line eradication study (CAP-3 study) |
| Primary sponsor | Yokohama City University Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Helicobacter pylori infection |
| Interventions | sitafloxacin(STFX) +amoxicillin(AMPC)+ P-CAB sitafloxacin(STFX) +amoxicillin(AMPC)+ PPI |
| Registration date | Jan 2, 2015 |
| Target size | 126 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: